Status:
COMPLETED
A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis
Lead Sponsor:
Astellas Pharma Inc
Collaborating Sponsors:
Astellas Pharma US, Inc.
Conditions:
Psoriasis
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis
Detailed Description
A long-term, open label, non-comparative, multi-center study to evaluate the safety of tacrolimus cream-B 0.1% in treating the signs and symptoms of psoriasis.
Eligibility Criteria
Inclusion
- Clinical diagnosis of plaque psoriasis
Exclusion
- Skin disorder other than plaque psoriasis in the areas to be treated.
- Disease on only scalp
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
658 Patients enrolled
Trial Details
Trial ID
NCT00293917
Start Date
January 1 2006
End Date
August 1 2007
Last Update
February 13 2008
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States, 30322
2
Fresno, California, United States, 93710
3
Santa Monica, California, United States, 90404
4
Vista, California, United States, 92083